ASTRAZEN
Invest with MTF
Invest Now
Invest in AstraZeneca Pharma India with 3.18X leverage
Performance
- Low
- ₹8,800
- High
- ₹9,199
- 52 Week Low
- ₹6,313
- 52 Week High
- ₹10,691
- Open Price₹9,199
- Previous Close₹9,168
- Volume26,353
Investment Returns
- Over 1 Month -1.32%
- Over 3 Month + 0.77%
- Over 6 Month -0.31%
- Over 1 Year + 39.64%
Smart Investing Starts Here Start SIP with AstraZeneca Pharma India for Steady Growth!
AstraZeneca Pharma India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 111.5
- PEG Ratio
- 0.8
- Market Cap Cr
- 22,198
- P/B Ratio
- 27.8
- Average True Range
- 185.93
- EPS
- 92.47
- Dividend Yield
- 0.4
- MACD Signal
- -19.15
- RSI
- 38.01
- MFI
- 41.7
AstraZeneca Pharma India Financials
AstraZeneca Pharma India Technicals
EMA & SMA
Current Price
₹8,879.00
-289
(-3.15%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹9,087.32
- 50 Day
- ₹9,106.35
- 100 Day
- ₹9,029.02
- 200 Day
- ₹8,683.64
Resistance and Support
8959.33
- R3 9,517.67
- R2 9,358.33
- R1 9,118.67
- S1 8,719.67
- S2 8,560.33
- S3 8,320.67
AstraZeneca Pharma India Corporate Actions - Bonus, Splits, Dividends
AstraZeneca Pharma India F&O
About AstraZeneca Pharma India
- NSE Symbol
- ASTRAZEN
- BSE Symbol
- 506820
- Managing Director
- Mr. Praveen Rao Akkinepally
- ISIN
- INE203A01020
Similar Stocks to AstraZeneca Pharma India
AstraZeneca Pharma India FAQs
AstraZeneca Pharma India share price is ₹8,879 As on 28 December, 2025 | 09:16
The Market Cap of AstraZeneca Pharma India is ₹22197.5 Cr As on 28 December, 2025 | 09:16
The P/E ratio of AstraZeneca Pharma India is 111.5 As on 28 December, 2025 | 09:16
The PB ratio of AstraZeneca Pharma India is 27.8 As on 28 December, 2025 | 09:16
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.